The store will not work correctly when cookies are disabled.
4-ethyl-3,4-dihydro-2H-benzo[b][1,4]oxazine-6-carboxylic acid
ID: ALA3800109
PubChem CID: 127047087
Max Phase: Preclinical
Molecular Formula: C11H13NO3
Molecular Weight: 207.23
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCN1CCOc2ccc(C(=O)O)cc21
Standard InChI: InChI=1S/C11H13NO3/c1-2-12-5-6-15-10-4-3-8(11(13)14)7-9(10)12/h3-4,7H,2,5-6H2,1H3,(H,13,14)
Standard InChI Key: YUKGJLQYUAGPCP-UHFFFAOYSA-N
Molfile:
RDKit 2D
15 16 0 0 0 0 0 0 0 0999 V2000
-4.9494 0.9039 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.9091 1.5019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2995 2.9981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9072 2.7019 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3396 3.5967 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
7 6 1 0
7 8 2 0
8 3 1 0
7 9 1 0
10 9 1 0
11 10 1 0
12 11 1 0
6 12 1 0
9 13 1 0
2 14 2 0
13 15 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 207.23 | Molecular Weight (Monoisotopic): 207.0895 | AlogP: 1.60 | #Rotatable Bonds: 2 |
Polar Surface Area: 49.77 | Molecular Species: ACID | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 5.04 | CX Basic pKa: 1.18 | CX LogP: 1.77 | CX LogD: -0.57 |
Aromatic Rings: 1 | Heavy Atoms: 15 | QED Weighted: 0.80 | Np Likeness Score: -1.04 |
References
1. Lee EC, Futatsugi K, Arcari JT, Bahnck K, Coffey SB, Derksen DR, Kalgutkar AS, Loria PM, Sharma R.. (2016) Optimization of amide-based EP3 receptor antagonists., 26 (11): [PMID:27107947] [10.1016/j.bmcl.2016.04.009] |